The US Budesonide Inhalers market is gaining opportunities through combination inhalers containing budesonide and other respiratory medicines. These products provide additional options for eligible patients, including certain individuals with asthma or COPD, according to product-specific prescribing information. The Budesonide Inhalers Market is expected to reach US$ 10.29 billion by 2031,...